Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Vulnerability of DHCR7+/- mutation carriers to aripiprazole and trazodone exposure.

Korade Z, Genaro-Mattos TC, Tallman KA, Liu W, Garbett KA, Koczok K, Balogh I, Mirnics K, Porter NA.

J Lipid Res. 2017 Nov;58(11):2139-2146. doi: 10.1194/jlr.M079475. Epub 2017 Sep 28.

2.

Gestational diabetes exacerbates maternal immune activation effects in the developing brain.

Money KM, Barke TL, Serezani A, Gannon M, Garbett KA, Aronoff DM, Mirnics K.

Mol Psychiatry. 2018 Sep;23(9):1920-1928. doi: 10.1038/mp.2017.191. Epub 2017 Sep 26.

3.

Human dermal fibroblasts in psychiatry research.

Kálmán S, Garbett KA, Janka Z, Mirnics K.

Neuroscience. 2016 Apr 21;320:105-21. doi: 10.1016/j.neuroscience.2016.01.067. Epub 2016 Feb 9. Review.

4.

An altered peripheral IL6 response in major depressive disorder.

Money KM, Olah Z, Korade Z, Garbett KA, Shelton RC, Mirnics K.

Neurobiol Dis. 2016 May;89:46-54. doi: 10.1016/j.nbd.2016.01.015. Epub 2016 Jan 22.

5.

Fibroblasts from patients with major depressive disorder show distinct transcriptional response to metabolic stressors.

Garbett KA, Vereczkei A, Kálmán S, Wang L, Korade Ž, Shelton RC, Mirnics K.

Transl Psychiatry. 2015 Mar 10;5:e523. doi: 10.1038/tp.2015.14.

6.

Metabolic consequences of interleukin-6 challenge in developing neurons and astroglia.

Brown JA, Sherrod SD, Goodwin CR, Brewer B, Yang L, Garbett KA, Li D, McLean JA, Wikswo JP, Mirnics K.

J Neuroinflammation. 2014 Nov 6;11:183. doi: 10.1186/s12974-014-0183-6.

7.

Coordinated messenger RNA/microRNA changes in fibroblasts of patients with major depression.

Garbett KA, Vereczkei A, Kálmán S, Brown JA, Taylor WD, Faludi G, Korade Ž, Shelton RC, Mirnics K.

Biol Psychiatry. 2015 Feb 1;77(3):256-265. doi: 10.1016/j.biopsych.2014.05.015. Epub 2014 Jun 2.

8.

Modulation of behavioral networks by selective interneuronal inactivation.

Schmidt MJ, Horvath S, Ebert P, Norris JL, Seeley EH, Brown J, Gellert L, Everheart M, Garbett KA, Grice TW, Caprioli RM, Mirnics K.

Mol Psychiatry. 2014 May;19(5):580-7. doi: 10.1038/mp.2013.167. Epub 2013 Dec 10.

9.

Metabolic stress-induced microRNA and mRNA expression profiles of human fibroblasts.

Kálmán S, Garbett KA, Vereczkei A, Shelton RC, Korade Z, Mirnics K.

Exp Cell Res. 2014 Jan 15;320(2):343-53. doi: 10.1016/j.yexcr.2013.10.019. Epub 2013 Nov 16.

10.

The role of cannabinoid 1 receptor expressing interneurons in behavior.

Brown JA, Horváth S, Garbett KA, Schmidt MJ, Everheart M, Gellért L, Ebert P, Mirnics K.

Neurobiol Dis. 2014 Mar;63:210-21. doi: 10.1016/j.nbd.2013.11.001. Epub 2013 Nov 13.

11.

Physical activity is linked to ceruloplasmin in the striatum of intact but not MPTP-treated primates.

Leak RK, Garbett KA, Dettmer AM, Zhang Z, Mirnics K, Cameron JL.

Cell Tissue Res. 2012 Dec;350(3):401-7. doi: 10.1007/s00441-012-1488-3. Epub 2012 Sep 2.

12.

Effects of maternal immune activation on gene expression patterns in the fetal brain.

Garbett KA, Hsiao EY, Kálmán S, Patterson PH, Mirnics K.

Transl Psychiatry. 2012 Apr 3;2:e98. doi: 10.1038/tp.2012.24.

13.

Novel animal models for studying complex brain disorders: BAC-driven miRNA-mediated in vivo silencing of gene expression.

Garbett KA, Horváth S, Ebert PJ, Schmidt MJ, Lwin K, Mitchell A, Levitt P, Mirnics K.

Mol Psychiatry. 2010 Oct;15(10):987-95. doi: 10.1038/mp.2010.1. Epub 2010 Feb 2.

14.

Yeast TFIID serves as a coactivator for Rap1p by direct protein-protein interaction.

Garbett KA, Tripathi MK, Cencki B, Layer JH, Weil PA.

Mol Cell Biol. 2007 Jan;27(1):297-311. Epub 2006 Oct 30.

15.

Mapping key functional sites within yeast TFIID.

Leurent C, Sanders SL, Demény MA, Garbett KA, Ruhlmann C, Weil PA, Tora L, Schultz P.

EMBO J. 2004 Feb 25;23(4):719-27. Epub 2004 Feb 12.

16.

Molecular characterization of Saccharomyces cerevisiae TFIID.

Sanders SL, Garbett KA, Weil PA.

Mol Cell Biol. 2002 Aug;22(16):6000-13.

Supplemental Content

Loading ...
Support Center